Home Tags Sorrento Therapeutics

Tag: Sorrento Therapeutics

What Do Wall Street Analysts Think Of Sorrento Therapeutics, Inc. (SRNE),...

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) recently ticked higher on strong volume. About 1407686 contracts were traded on 16-Jan-19 compared to daily average volume of 1064440...

Is There Some Concern About The Royal Bank of Scotland Group...

One of the trending stocks on Friday was The Royal Bank of Scotland Group plc (NYSE:RBS). The number of shares transacted for the day...

Looking At The Big Picture: Sorrento Therapeutics, Inc. (SRNE), Oshkosh Corporation...

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) attracted a lower number of shares in volume with 899885 contracts traded on 10-Jan-19. However, its trading capacity stayed around...

Should Value Investors Consider R1 RCM Inc. (RCM) And Sorrento Therapeutics,...

R1 RCM Inc. (NASDAQ:RCM)'s price-to-sales ratio of 1.36 is creating a long-term opportunity in the value in its stock. The broad Other Consumer Services...

Why the Top Analysts Have Mixed Views on Switch, Inc. (SWCH),...

Switch, Inc. (NYSE:SWCH) recently had a low trading volume day. The volume for the company on 08-Jan-19 was recorded to be 976743 contracts. Over...

Sorrento Therapeutics, Inc. (SRNE): What Does The Future Look Like?

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) went up to recover about 40.51% since recording its record low price of $1.95. The stock experienced 6.2% jump, arriving...

Why the Top Analysts Have Mixed Views on Rent-A-Center, Inc. (RCII),...

Rent-A-Center, Inc. (NASDAQ:RCII) recently had a high trading volume day. The volume for the company on 04-Jan-19 was recorded to be 1.99 million contracts....

Cheaper Or Expensive Than Peers? – SS&C Technologies Holdings, Inc. (SSNC),...

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) is expensive when one looks at the company's price to sales ratio of 3.99 and compares it with other...

Analysts Are Gushing Over Sorrento Therapeutics, Inc. (SRNE), Conduent Incorporated (CNDT)

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) last session’s volume of 1.67 million shares was higher than its average volume of 1.6 million shares. The stock, after...

Is There A Resounding Lack Of Confidence In Sorrento Therapeutics, Inc....

Heading into the close, a volume-active day saw Sorrento Therapeutics, Inc. (NASDAQ:SRNE) moving up $0.19 from the opening price. The volume for the company...